Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Axim Biotechnologies (AXIM)

Axim Biotechnologies (AXIM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AXIM with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5900 +4.24%
on 09/24/20
0.7300 -15.75%
on 09/21/20
-0.0850 (-12.14%)
since 09/18/20
3-Month
0.5550 +10.81%
on 08/21/20
1.1900 -48.32%
on 07/20/20
-0.4350 (-41.43%)
since 07/17/20
52-Week
0.1000 +515.00%
on 03/23/20
1.4400 -57.29%
on 07/16/20
+0.0350 (+6.03%)
since 10/18/19

Most Recent Stories

More News
Medical Marijuana, Inc. Investment Company AXIM(R) Biotechnologies Files Patent for World's First Face Mask Designed to Capture SARS-CoV-2 (COVID-19)

via NewMediaWire -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical...

MJNA : 0.0134 (-2.19%)
AXIM : 0.6200 (-3.09%)
AXIM(R) Biotechnologies Files Patent for World's First Face Mask Designed to Capture SARS-CoV-2 COVID-19

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that...

AXIM : 0.6200 (-3.09%)
AXIM(R) Biotechnologies Receives Notice of U.S. Patent Allowance for Proprietary Compounds and Methods Targeting Tumor Metastasis Through QSOX1

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that...

AXIM : 0.6200 (-3.09%)
AXIM(R) Biotechnologies Files Emergency Use Authorization With the FDA for First-in-Class COVID-19 Rapid Diagnostic Test for Neutralizing Antibodies

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announced today it has...

AXIM : 0.6200 (-3.09%)
AXIM(R) Biotechnologies Signs Exclusive Licensing, Manufacturing and Distribution Agreement for High Volume Production of the COVID-19 Rapid Neutralizing Antibody Test

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that...

AXIM : 0.6200 (-3.09%)
Sapphire Biotech, Subsidiary of AXIM(R) Biotechnologies, Awarded Prestigious Phase I Small Business Innovation Research Grant by National Cancer Institute

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announces that its wholly-owned...

AXIM : 0.6200 (-3.09%)
AXIM(R) Biotechnologies Applies for FDA Emergency Use Approval (EUA) for High Throughput, Patent-Pending Neutralizing Antibody Diagnostic Test for COVID-19

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announced today the...

AXIM : 0.6200 (-3.09%)
AXIM(R) Biotechnologies Appoints Dr. Alim Seit-Nebi as Chief Technology Officer of Subsidiary Sapphire Biotech

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological research, announced today it has appointed...

AXIM : 0.6200 (-3.09%)
AXIM(R) Biotechnologies Begins Pre-Clinical Pharmacokinetic Animal Drug Studies on its Cancer Drug Compound SPX-1009

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological research, announced today that its subsidiary...

AXIM : 0.6200 (-3.09%)
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Expands Research Division and Announces Dr. Sergei Svarovsky as Chief Scientific Officer of Subsidiary Sapphire Biotech

, /PRNewswire/ --  (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands...

MJNA : 0.0134 (-2.19%)
AXIM : 0.6200 (-3.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

2nd Resistance Point 0.6733
1st Resistance Point 0.6565
Last Price 0.6200
1st Support Level 0.6165
2nd Support Level 0.5933

See More

52-Week High 1.4400
Fibonacci 61.8% 0.9281
Fibonacci 50% 0.7700
Last Price 0.6200
Fibonacci 38.2% 0.6119
52-Week Low 0.1000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar